SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 106.48   -1.33 (-1.23%) Volume: 260.61k 4:00 PM EDT Oct 16, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
3Initial statement of beneficial ownership of securities110/15/2019
8-KCurrent report pursuant to Section 13 or 15(d)410/16/2019
4Statement of changes in beneficial ownership of securities110/16/2019
4/A[Amend] Statement of changes in beneficial ownership of securities109/24/2019
4Statement of changes in beneficial ownership of securities109/23/2019
4Statement of changes in beneficial ownership of securities109/23/2019
8-KCurrent report pursuant to Section 13 or 15(d)209/11/2019
8-KCurrent report pursuant to Section 13 or 15(d)209/11/2019
4Statement of changes in beneficial ownership of securities109/05/2019
4Statement of changes in beneficial ownership of securities109/04/2019
4Statement of changes in beneficial ownership of securities109/03/2019
4Statement of changes in beneficial ownership of securities108/13/2019
10-QGeneral form for quarterly reports under Section 13 or 15(d)608/08/2019
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans608/08/2019
4Statement of changes in beneficial ownership of securities108/06/2019
<<
First
<
Prev
123456789101112131415